oxymetazoline has been researched along with Conjunctival Diseases in 1 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
Conjunctival Diseases: Diseases involving the CONJUNCTIVA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez-Saldivar, G | 1 |
| Pita-Ortiz, IY | 1 |
| Flores-Villalobos, EO | 1 |
| Jaurrieta-Hinojos, JN | 1 |
| Espinosa-Soto, I | 1 |
| Rios-Nequis, G | 1 |
| Ramirez-Estudillo, A | 1 |
| Jimenez-Rodriguez, M | 1 |
1 other study available for oxymetazoline and Conjunctival Diseases
| Article | Year |
|---|---|
Oxymetazoline: reduction of subconjunctival hemorrhage incidence after intravitreal injections.
Topics: Adrenergic alpha-Agonists; Aged; Conjunctiva; Conjunctival Diseases; Diabetic Retinopathy; Double-Bl | 2019 |